Paramanandam Vincent Singh, Dylke Elizabeth, Fu Mei R, Daptardar Anuradha, Kamat Manali, Mahajan Sarika, Kilbreath Sharon
Macquarie University, Sydney, New South Wales, Australia.
The University of Sydney, New South Wales, Australia.
J Transcult Nurs. 2025 Jun 28;36(5):10436596251345338. doi: 10.1177/10436596251345338.
Breast cancer-related lymphedema is associated with a myriad of distressing symptoms and significantly impacts survivors' quality of life. The Breast Cancer-related Lymphedema Symptom Experience Index (BCLE-SEI) is a validated patient-reported outcome measure (PROM), but is unavailable in Indian languages. This study aimed to cross-culturally adapt the BCLE-SEI into the Bengali language.
Following established guidelines, the BCLE-SEI was translated, back-translated, and validated in 168 Bengali-speaking women with or at risk of lymphedema.
Content validity was confirmed by ≥98% of participants. Exploratory factor analysis identified two factors in symptom occurrence and distress subscales, explaining 43.9% and 51% of the variance, respectively. Internal consistency (α) was >0.85, and construct validity was supported with over 50% of predefined hypotheses met. Test-retest reliability (intraclass correlation coefficient [ICC]) was .46 (95% confidence interval [CI] = [-0.2, 0.8], = .076).
The BCLE-SEI-Bengali is a reliable and valid PROM for assessing lymphedema-related symptoms for Bengali-speaking women.
乳腺癌相关淋巴水肿与众多令人痛苦的症状相关,对幸存者的生活质量有显著影响。乳腺癌相关淋巴水肿症状体验指数(BCLE - SEI)是一种经过验证的患者报告结局指标(PROM),但没有印度语言版本。本研究旨在将BCLE - SEI进行跨文化改编,使其成为孟加拉语版本。
按照既定指南,对168名有淋巴水肿或有淋巴水肿风险的孟加拉语女性进行了BCLE - SEI的翻译、回译和验证。
≥98%的参与者确认了内容效度。探索性因子分析在症状发生和困扰子量表中确定了两个因子,分别解释了43.9%和51%的方差。内部一致性(α)>0.85,超过50%的预定义假设得到满足,支持了结构效度。重测信度(组内相关系数[ICC])为0.46(95%置信区间[CI]=[-0.2, 0.8],P = 0.076)。
BCLE - SEI孟加拉语版是一种可靠且有效的PROM,用于评估孟加拉语女性的淋巴水肿相关症状。